Susquehanna International Group
PRME icon

Susquehanna International Group’s Prime Medicine PRME Stock Holding History

Susquehanna International Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$651K Buy
187,000
+121,500
+185% +$462K ﹤0.01% 8986
2025
Q4 		$227K Sell
65,500
-334,000
-84% -$1.49M ﹤0.01% 10589
2025
Q3 		$2.21M Buy
399,500
+314,300
+369% +$1.28M ﹤0.01% 5560
2025
Q2 		$210K Buy
+85,200
New +$131K ﹤0.01% 11109
2024
Q4 		– Sell
-233,800
Closed -$905K – 12998
2024
Q3 		$905K Buy
233,800
+180,800
+341% +$838K ﹤0.01% 7018
2024
Q2 		$272K Buy
+53,000
New +$321K ﹤0.01% 9664

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Susquehanna International Group's PRME Position: Q1 2026 in Review

Susquehanna International Group reduced its Prime Medicine (PRME) stake by 39% in Q1 2026, selling an estimated $1.75M and leaving 715,829 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #5660.

Susquehanna International Group first reported a position in PRME in Q2 2023 and has held it in 11 quarters since. The position peaked at $4.08M in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Susquehanna International Group held 715,829 shares of Prime Medicine worth $2.49M as of Q1 2026.
  • Susquehanna International Group sold 460,898 Prime Medicine shares in Q1 2026, an estimated $1.75M.
  • Prime Medicine made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5660 holding.
  • Susquehanna International Group first reported a position in Prime Medicine in Q2 2023 and has held it in 11 quarters since.
  • Susquehanna International Group's Prime Medicine position peaked at $4.08M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.